MedPath

REGIOCIT

REGIOCIT

Approved
Approval ID

6fa432f1-7cde-4840-80f0-1be19a76f318

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 13, 2020

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Chloride, Sodium Citrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24571-123
Product Classification
G
Generic Name
Sodium Chloride, Sodium Citrate
Product Specifications
Route of AdministrationEXTRACORPOREAL
Effective DateAugust 13, 2020
FDA Product Classification

INGREDIENTS (4)

SODIUM CHLORIDEActive
Quantity: 5.03 g in 1000 mL
Code: 451W47IQ8X
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMActive
Quantity: 5.29 g in 1000 mL
Code: 1Q73Q2JULR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REGIOCIT - FDA Drug Approval Details